About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

She's in bed waiting, and you can't track down where on your body that smell is coming from. Make sure you're clean for her ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

The World Health Organization (WHO) has called for access expansion to newly approved human immunodeficiency virus (HIV) medication amid “sharp and sudden” global funding cuts. This year has been a ...

On top of offering various PrEP and PEP medications to students, Student Health expanded its HIV prevention medications this semester with lenacapavir, a twice-per-year injection the Food and Drug ...

Offering diverse PrEP options enhances adherence and reduces HIV cases, with injectable forms showing promise due to less frequent dosing. The study found that MSM in Australia prefer various PrEP ...

PARIS — The landscape of “chemsex” in Europe is changing and could be putting users at a higher risk for sexually transmitted infections (STIs), according to new findings presented last week at the ...

Tamar Braxton wants Black women to put their sexual health first. The Grammy-nominated singer, chef, and actress has announced a new brand partnership with Gilead Sciences, the pharmaceutical giant ...

– Gilead’s Research Presentations and Community Events at IAS Reflect Commitment to Partnerships in Developing Person-Centered Options for a Diverse Range of Populations – FOSTER CITY, ...

As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company is doing so with a key potential overhang removed. Friday, the U.S.